Singh P, Zumpf KB, Liszewski W. Rates of genital warts after the age of 26: an analysis of the National Health and Nutrition Examination Survey. Int J Womens Dermatol. 2020;6(5):429-430.
Berna R, Margolis DJ, Barbieri JS. Annual health care utilization and costs for treatment of cutaneous and anogenital warts among a commercially insured population in the US, 2017–2019. JAMA Dermatol. 2022;158(6):695-697.
Dinh TH, Sternberg M, Dunne EF, et al. Genital warts among 18- to 59-year-olds in the United States, National Health and Nutrition Examination Survey, 1999–2004. Sex Transm Dis. 2008;35(4):357-360.
Patel H, Wagner M, Singhal P, et al. Systematic review of the incidence and prevalence of genital warts. BMC Infect Dis. 2013;13:39.
Workowski KA, Bachmann LH, Chan PA, et al.; Centers for Disease Control and Prevention (CDC). Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1-187.
Nugent D, Apoola A, Coleman H, et al. British association for sexual health and HIV national guideline for the management of anogenital warts in adults (2024). Int J STD AIDS. 2024;35(7):498-509.
Winer RL, Lee SK, Hughes JP, et al. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol. 2003;157(3):218-226.
Brianti P, De Flammineis E, Mercuri SR. Review of HPV-related diseases and cancers. New Microbiol. 2017;40(2):80-85.
Bacaj P, Burch D. Human papillomavirus infection of the skin. Arch Pathol Lab Med. 2018;142(6):700-705.
Coleman N, Birley HD, Renton AM, et al. Immunological events in regressing genital warts. Am J Clin Pathol. 1994;102(6):768-774.
Winer RL, Kiviat NB, Hughes JP, et al. Development and duration of human papillomavirus lesions, after initial infection. J Infect Dis. 2005;191(5):731-738.
Arima Y, Winer RL, Feng Q, et al. Development of genital warts after incident detection of human papillomavirus infection in young men. J Infect Dis. 2010;202(8):1181-1184.
Lacey CJN. Therapy for genital human papillomavirus-related disease. J Clin Virol. 2005;32(suppl 1):S82-S90.
Tyros G, Mastraftsi S, Gregoriou S, et al. Incidence of anogenital warts: epidemiological risk factors and real-life impact of human papillomavirus vaccination. Int J STD AIDS. 2021;32(1):4-13.
Meites E, Kempe A, Markowitz LE. Use of a 2-dose schedule for human papillomavirus vaccination – updated recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2016;65(49):1405-1408.
Meites E, Szilagyi PG, Chesson HW, et al. Human papillomavirus vaccination for adults: updated recommendation of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2019;68(32):698-702.
Sharpless KE, Marcus JZ, Kuroki LM, et al. ASCCP committee opinion: adjuvant human papillomavirus vaccine for patients undergoing treatment for cervical intraepithelial neoplasia. J Low Genit Tract Dis. 2023;27(1):93-96.
Kjaer SK, Nygård M, Sundström K, et al. Final analysis of a 14-year long-term follow-up study of the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in women from four Nordic countries. EClinicalMedicine. 2020;23:100401.
Rosenblum HG, Lewis RM, Gargano JW, et al. Declines in prevalence of human papillomavirus vaccine-type infection among females after introduction of vaccine – United States, 2003–2018. MMWR Morb Mortal Wkly Rep. 2021;70(12):415-420.
Drolet M, Bénard É, Pérez N, et al.; HPV Vaccination Impact Study Group. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis. Lancet. 2019;394(10197):497-509.
Hansen BT, Hagerup-Jenssen M, Kjaer SK, et al. Association between smoking and genital warts: longitudinal analysis. Sex Transm Infect. 2010;86(4):258-262.
Bencini PL, Guida S, Cazzaniga S, et al. Risk factors for recurrence after successful treatment of warts: the role of smoking habits. J Eur Acad Dermatol Venereol. 2017;31(4):712-716.
Wen LM, Estcourt CS, Simpson JM, et al. Risk factors for the acquisition of genital warts: are condoms protective? Sex Transm Infect. 1999;75(5):312-316.
Sonnenberg P, Tanton C, Mesher D, et al. Epidemiology of genital warts in the British population: implications for HPV vaccination programmes. Sex Transm Infect. 2019;95(5):386-390.
Cocchio S, Bertoncello C, Baldovin T, et al. Self-reported genital warts among sexually-active university students: a cross-sectional study. BMC Infect Dis. 2018;18(1):41.
Dareng EO, Adebamowo SN, Famooto A, et al. Prevalence and incidence of genital warts and cervical human papillomavirus infections in Nigerian women. BMC Infect Dis. 2019;19(1):27.
Kjaer SK, Tran TN, Sparen P, et al. The burden of genital warts: a study of nearly 70,000 women from the general female population in the 4 Nordic countries. J Infect Dis. 2007;196(10):1447-1454.
Wiley DJ, Harper DM, Elashoff D, et al. How condom use, number of receptive anal intercourse partners and history of external genital warts predict risk for external anal warts. Int J STD AIDS. 2005;16(3):203-211.
Larke N, Thomas SL, Dos Santos Silva I, et al. Male circumcision and human papillomavirus infection in men: a systematic review and meta-analysis. J Infect Dis. 2011;204(9):1375-1390.
Zhu YP, Jia ZW, Dai B, et al. Relationship between circumcision and human papillomavirus infection: a systematic review and meta-analysis. Asian J Androl. 2017;19(1):125-131.
Lynde C, Vender R, Bourcier M, et al. Clinical features of external genital warts. J Cutan Med Surg. 2013;17(suppl 2):S55-S60.
O’Mahony C, Gomberg M, Skerlev M, et al. Position statement for the diagnosis and management of anogenital warts. J Eur Acad Dermatol Venereol. 2019;33(6):1006-1019.
Park IU, Introcaso C, Dunne EF. Human papillomavirus and genital warts: a review of the evidence for the 2015 Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines. Clin Infect Dis. 2015;61(suppl 8):S849-S855.
Thurgar E, Barton S, Karner C, et al. Clinical effectiveness and cost-effectiveness of interventions for the treatment of anogenital warts: systematic review and economic evaluation. Health Technol Assess. 2016;20(24):v-vi.
Mehdi MH, Mahmood AS. Treatment of genital warts by using CO2 laser. Med J Babylon. 2019;16(2):94-98.
Azizjalali M, Ghaffarpour G, Mousavifard B. CO(2) laser therapy versus cryotherapy in treatment of genital warts; a randomized controlled trial (RCT). Iran J Microbiol. 2012;4(4):187-190.
Centers for Medicare and Medicaid Services. Search the physician fee schedule. Accessed November 27, 2024. https://www.cms.gov/medicare/physician-fee-schedule/search
Fox-Lewis A, Allum C, Vokes D, et al. Human papillomavirus and surgical smoke: a systematic review. Occup Environ Med. 2020;77(12):809-817.
Barton S, Wakefield V, O’Mahony C, et al. Effectiveness of topical and ablative therapies in treatment of anogenital warts: a systematic review and network meta-analysis. BMJ Open. 2019;9(10):e027765.
Bertolotti A, Ferdynus C, Milpied B, et al. Local management of anogenital warts in non-immunocompromised adults: a network meta-analysis of randomized controlled trials. Dermatol Ther (Heidelb). 2020;10(2):249-262.
Jung JM, Jung CJ, Lee WJ, et al. Topically applied treatments for external genital warts in nonimmunocompromised patients: a systematic review and network meta-analysis. Br J Dermatol. 2020;183(1):24-36.
Centers for Medicare and Medicaid Services. Billing and coding: removal of benign skin lesions. Accessed August 8, 2024. https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleid=54602&ver=17&bc=0
Karnes JB, Usatine RP. Management of external genital warts. Am Fam Physician. 2014;90(5):312-318.
Kodner CM, Nasraty S. Management of genital warts. Am Fam Physician. 2004;70(12):2335-2342.